Comparison of application of 2013 ACC/AHA guideline and 2011 European Society of Cardiology guideline for the management of dyslipidemias for primary prevention in a Turkish cohort

• Published in: Anatolian journal of cardiology 2017-02, Vol.17 (2), p.92-96
• Main Authors: Yılmaz, Mustafa, Atar, İlyas, Hasırcı, Senem, Akyol, Kadirhan, Tekin, Abdullah, Karaçağlar, Emir, Çiftçi, Orçun, Müderrisoğlu, Haldun
• Format: Article
• Language: English
• Subjects: Original Investigation
• ISSN: 2149-2263; 2149-2271
• DOI: 10.14744/AnatolJCardiol.2016.6965

Atherosclerotic cardiovascular disease is a major global cause of death. The common approach in primary prevention of cardiovascular disease is to identify patients at high risk for cardiovascular disease. This article analyzes and compares the application of 2013 American College of Cardiology/American Heart Association (ACC/AHA) guideline and the 2011 European Society of Cardiology (ESC) guideline for the management of dyslipidemias for primary prevention in Turkish population. The study included 833 patients (482 women and 351 men). Risk scores were calculated according to both guidelines and indications for statin treatment were determined according to sex and age group. Variables are presented as mean±SD or median with interquartile range for continuous data and as proportions for categorical data. Variables were analyzed by unpaired t-test, Mann-Whitney U test, chi-square or Fischer's exact test as appropriate. The ACC/AHA would suggest statin treatment in 415 patients out of 833 (49.5%), while ESC would recommend statin for 193 patients out of 833 (23.1%)(p